RIZATRIPTAN ACTAVIS rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Prieinama:

Medis Pharma Pty Ltd

INN (Tarptautinis Pavadinimas):

rizatriptan benzoate

Vaisto forma:

Tablet, orally disintegrating

Sudėtis:

Excipient Ingredients: calcium silicate; magnesium stearate; mannitol; aspartame; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; Flavour

Vartojimo būdas:

Oral

Vienetai pakuotėje:

2, 6, 3

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

RIZATRIPTAN ACTAVIS is indicated for the acute treatment of migraine attacks with or without aura.

Produkto santrauka:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 5" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Autorizacija statusas:

Licence status A

Leidimo data:

2015-02-19